CTC (Chicago Trading Company)’s BioNTech BNTX Stock Holding History

CTC (Chicago Trading Company)’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,124	Closed	-$435K	–	310
2023 Q4	$435K	Sell	4,124 -1,351	-25%	-$136K	﹤0.01%	301
2023 Q3	$595K	Sell	5,475 -7,723	-59%	-$854K	﹤0.01%	325
2023 Q2	$1.42M	Sell	13,198 -12,782	-49%	-$1.44M	﹤0.01%	289
2023 Q1	$3.18M	Buy	25,980 +18,542	+249%	+$2.55M	﹤0.01%	295
2022 Q4	$1.12M	Buy	+7,438	New	+$1.14M	﹤0.01%	286
2022 Q1	–	Sell	-40,605	Closed	-$6.82M	–	292
2021 Q4	$10.5M	Buy	40,605 +2,851	+8%	+$781K	﹤0.01%	196
2021 Q3	$10.3M	Buy	+37,754	New	+$12M	0.01%	137

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

CTC (Chicago Trading Company)'s BNTX Position: Q1 2024 in Review

CTC (Chicago Trading Company) sold out of BioNTech (BNTX) in Q1 2024, closing a stake of 4,124 shares — an estimated $435K sold.

CTC (Chicago Trading Company) first reported a position in BNTX in Q3 2021 and held it in 7 quarters. The position peaked at $10.5M in Q4 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2024.

CTC (Chicago Trading Company) reported no remaining BioNTech position as of Q1 2024 after selling out during the quarter.
CTC (Chicago Trading Company) sold 4,124 BioNTech shares in Q1 2024, an estimated $435K.
CTC (Chicago Trading Company) first reported a position in BioNTech in Q3 2021 and held it in 7 quarters.
CTC (Chicago Trading Company)'s BioNTech position peaked at $10.5M in Q4 2021.
287 funds tracked by Wall St. Rank held BioNTech as of Q1 2024.

Based on CTC (Chicago Trading Company)'s 13F filing for Q1 2024, filed 15 May 2024.